Press Releases
17 December 2018
DUBLIN--(BUSINESS WIRE)-- The "Global Coupling Market - by Product, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering. The Global Coupling Market is estimated to grow with a CAGR of 2.24%
Read more...17 December 2018
DUBLIN--(BUSINESS WIRE)-- The "Global Camper Market - by Type, Roof Type, Application, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering. The Global Camper Market was worth 85.5 Billi
Read more...MEDFORD, Ore.--(BUSINESS WIRE)-- Lithia Motors, Inc. (NYSE: LAD) today reported the highest third quarter revenue and earnings per share in company history. Third quarter 2018 revenue increased 15% to $3.1 billion from $2.7 billion in the third quarter of 2017. Third quarter 2018 net income per diluted share was $3.84, an 86% increase over $2.07 per diluted share reported in the third quar
Read more...Dermatological Burns, Scars & Ulcers: 2018 Drug Development Pipeline Review - ResearchAndMarkets.com
17 December 2018
The "Dermatological Burns, Scars and Ulcers Drug Development Pipeline Review, 2018" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the pipeline landscape for dermatological burns, scars and ulcers. It provides comprehensive information on the therapeutics under development and key
Read more...17 December 2018
OXFORD, England--(BUSINESS WIRE)-- Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex’s entire infectious disease vaccin
Read more...17 December 2018
SAN DIEGO--(BUSINESS WIRE)-- TP Therapeutics, a clinical-stage precision oncology company developing novel drugs that address treatment resistance, and Almac Diagnostic Services, a global precision medicine company, today announced a global collaboration agreement to develop and commercialize a next-generation sequencing (NGS) companion diagnostic (CDx) for repotrectinib, TP Therapeutics’ investigational
Read more...17 December 2018
TOKYO--(BUSINESS WIRE)-- Stem cell discoverer Prof. James Till, Professor Emeritus, University of Toronto, Canada who was awarded the Edogawa Niche Prize 2018 (www.edoga
Read more...17 December 2018
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Please replace the graphic with the accompanying corrected graphic. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181024005283/en/ The release reads: SOUNDHOUND INC. AND HONDA
Read more...SANTA CLARA, Calif.--(BUSINESS WIRE)-- SoundHound Inc.®, the leading innovator in voice-enabled AI and conversational intelligence technologies, today announced a strategi
Read more...17 December 2018
THOUSAND OAKS, Calif.--(BUSINESS WIRE)-- Teledyne Technologies Incorporated (NYSE:TDY): Record third quarter sales of $725.3 million, an increase of 9.5% compared to last year All-time record GAAP earnings per diluted share of $2.43 Record third quarter ope
Read more...SHANGHAI & BEIJING--(BUSINESS WIRE)-- Delos and its China affiliate announced today the launching of the beta site for its Sourced by Delos program in collaboration with GIGA’s global sustainability product data hub, Origin. The Sourced by Delos program will provide the healthy building industry with online access to thousands of products and materials sourced through global product banks f
Read more...17 December 2018
PHILADELPHIA--(BUSINESS WIRE)-- Wolters Kluwer, Health announced today that the Chief Nurse of Health Lear
Read more...17 December 2018
MACON, Ga.--(BUSINESS WIRE)-- Blue Bird Corporation (NASDAQ: BLBD) (the “Company”) today announced the exercise of the Company’s right to convert all outstanding shares of its 7.625% Convertible Cumulative Preferred Stock, Series A (“Series A Preferred Stock”) into shares of common stock, $0.0001 per share, of the Company (“Common Stock”), subject to a beneficial ownership lim
Read more...17 December 2018
PHILADELPHIA--(BUSINESS WIRE)-- Radiation oncologists at Northwell Health, New York State’s largest healthcare provider, have partnered with
Read more...17 December 2018
PHOENIX--(BUSINESS WIRE)-- Carvana Co. (NYSE: CVNA), a leading e-commerce platform for buying, financing and selling used cars, today announced it will host an analyst day on Thursday, Nov. 29, 2018, in Phoenix. Carvana CEO Ernie Garcia will be joined by the senior management team to discuss the company’s long-term outlook and Carvana’s technology foundation. A live webcast of the event, along with
Read more...